PMC:7306567 / 33209-33580 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T165","span":{"begin":91,"end":94},"obj":"Disease"},{"id":"T166","span":{"begin":155,"end":158},"obj":"Disease"},{"id":"T167","span":{"begin":195,"end":198},"obj":"Disease"},{"id":"T168","span":{"begin":222,"end":225},"obj":"Disease"},{"id":"T169","span":{"begin":260,"end":263},"obj":"Disease"},{"id":"T170","span":{"begin":273,"end":276},"obj":"Disease"},{"id":"T171","span":{"begin":300,"end":302},"obj":"Disease"},{"id":"T172","span":{"begin":332,"end":335},"obj":"Disease"},{"id":"T173","span":{"begin":345,"end":348},"obj":"Disease"}],"attributes":[{"id":"A165","pred":"mondo_id","subj":"T165","obj":"http://purl.obolibrary.org/obo/MONDO_0010088"},{"id":"A166","pred":"mondo_id","subj":"T166","obj":"http://purl.obolibrary.org/obo/MONDO_0010088"},{"id":"A167","pred":"mondo_id","subj":"T167","obj":"http://purl.obolibrary.org/obo/MONDO_0010088"},{"id":"A168","pred":"mondo_id","subj":"T168","obj":"http://purl.obolibrary.org/obo/MONDO_0006687"},{"id":"A169","pred":"mondo_id","subj":"T169","obj":"http://purl.obolibrary.org/obo/MONDO_0006687"},{"id":"A170","pred":"mondo_id","subj":"T170","obj":"http://purl.obolibrary.org/obo/MONDO_0010088"},{"id":"A171","pred":"mondo_id","subj":"T171","obj":"http://purl.obolibrary.org/obo/MONDO_0017319"},{"id":"A172","pred":"mondo_id","subj":"T172","obj":"http://purl.obolibrary.org/obo/MONDO_0006687"},{"id":"A173","pred":"mondo_id","subj":"T173","obj":"http://purl.obolibrary.org/obo/MONDO_0010088"}],"text":"BJA Rijnders was the investigator for studies supported by Gilead Sciences, Janssen-Cilag, MSD, Pfizer, ViiV; has received research grants from Gilead and MSD; was an invited speaker for Gilead, MSD, Pfizer, Jansen-Cilag, BMS; and an advisory board member for BMS, Abbvie, MSD, Gilead, Jansen-Cilag; he received travel support from BMS, Abbvie, MSD, Gilead, Jansen-Cilag."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T218","span":{"begin":110,"end":113},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"BJA Rijnders was the investigator for studies supported by Gilead Sciences, Janssen-Cilag, MSD, Pfizer, ViiV; has received research grants from Gilead and MSD; was an invited speaker for Gilead, MSD, Pfizer, Jansen-Cilag, BMS; and an advisory board member for BMS, Abbvie, MSD, Gilead, Jansen-Cilag; he received travel support from BMS, Abbvie, MSD, Gilead, Jansen-Cilag."}

{"project":"LitCovid-sentences","denotations":[{"id":"T247","span":{"begin":0,"end":371},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"BJA Rijnders was the investigator for studies supported by Gilead Sciences, Janssen-Cilag, MSD, Pfizer, ViiV; has received research grants from Gilead and MSD; was an invited speaker for Gilead, MSD, Pfizer, Jansen-Cilag, BMS; and an advisory board member for BMS, Abbvie, MSD, Gilead, Jansen-Cilag; he received travel support from BMS, Abbvie, MSD, Gilead, Jansen-Cilag."}